HEREDITARY C5 DIFICIENCY IN MAN: GENETIC LINKAGE STUDIES.ROSENFELD SI; WEITKAMP LR; WARD F et al.1977; J. IMMUNOL.; U.S.A.; DA. 1977; VOL. 119; NO 2; PP. 604-608; BIBL. 33 REF.Article

HEREDITARY DEFICIENCY OF THE FIFTH COMPONENT OF COMPLEMENT IN MAN. I. CLINICAL, IMMUNOCHEMICAL, AND FAMILY STUDIES.ROSENFELD SI; KELLY ME; LEDDY JP et al.1976; J. CLIN. INVEST.; U.S.A.; DA. 1976; VOL. 57; NO 6; PP. 1626-1634; BIBL. 1 P. 1/2Article

MEMBRANE DAMAGE BY COMPLEMENTMAYER MM; MICHAELS DW; RAMM LE et al.1981; C.R.C. CRIT. REV. IMMUNOL.; USA; DA. 1981; VOL. 2; NO 2; PP. 133-165; BIBL. 93 REF.Article

A NEW FUNCTION OF THE ACTIVATED THIRD COMPONENT OF COMPLEMENT: BINDING TO C5, AN ESSENTIAL STEP FOR C5 ACTIVATION.VOGT W; SCHMIDT G; VON BUTTLAR B et al.1978; IMMUNOLOGY; G.B.; DA. 1978; VOL. 34; NO 1; PP. 29-40; BIBL. 16 REF.Article

The effect of ethylenedinitrilotetraacetic acid (EDTA) on the reaction between the guinea-pig C5 convertase and guinea-pig C5EVANS, B. D; AMIRAIAN, K.Molecular immunology. 1984, Vol 21, Num 5, pp 383-387, issn 0161-5890Article

COMPLEMENT (C5)-DERIVED CHEMOTACTIC ACTIVITY IN SERUM FROM PATIENTS WITH PANCREATITISPEREZ HD; HORN JK; ONG R et al.1983; J. LAB. CLIN. MED.; ISSN 0022-2143; USA; DA. 1983; VOL. 101; NO 1; PP. 123-129; BIBL. 23 REF.Article

SERUM LIPOPROTEINS AND C567-INH ACTIVITY.LINT TF; BEHRENDS CL; GEWURZ H et al.1977; J. IMMUNOL.; U.S.A.; DA. 1977; VOL. 119; NO 3; PP. 883-888; BIBL. 28 REF.Article

INCOMPATIBILITY BETWEEN COMPLEMENT COMPONENTS C3 AND C5 OF GUINEA-PIG AND MAN, AN INDUCTION OF THEIR INTERACTION IN C5 ACTIVATION BY CLASSICAL AND ALTERNATIVE C5 CONVERTASESVON ZABERN I; NOLTE R; VOGT W et al.1979; SCAND. J. IMMUNOL.; NOR; DA. 1979; VOL. 9; NO 1; PP. 69-74; BIBL. 19 REF.Article

The activation of human complement component C5 by a fluid phase C5 convertaseDISCIPIO, R. G; SMITH, C. A; MULLER-EBERHARD, H. J et al.The Journal of biological chemistry (Print). 1983, Vol 258, Num 17, pp 10629-10636, issn 0021-9258Article

Complement proteins C5b-9 induce transbilayer migration of membrane phospholipidsVAN DER MEER, B; FUGATE, R. D; SIMS, P. J et al.Biophysical journal. 1989, Vol 56, Num 5, pp 935-946, issn 0006-3495, 12 p.Article

Interaction of Zn²⁺ with guinea-pig C5 convertase and guinea-pig C5EVANS, B. D; AMIRAIAN, K.Molecular immunology. 1984, Vol 21, Num 1, pp 69-76, issn 0161-5890Article

Labeling the granulocyte C5a receptor with a unique photoreactive probeJOHNSON, R. J; CHENOWETH, D. E.The Journal of biological chemistry (Print). 1985, Vol 260, Num 12, pp 7161-7164, issn 0021-9258Article

ISOLATION AND CHARACTERIZATION OF THE THIRD AND FIFTH COMPONENTS OF RABBIT COMPLEMENTGICLAS PC; KEELING PJ; HENSON PM et al.1981; MOL. IMMUNOL.; ISSN 0161-5890; GBR; DA. 1981; VOL. 18; NO 2; PP. 113-123; BIBL. 15 REF.Article

FIFTH COMPONENT OF HUMAN COMPLEMENT: PURIFICATION FROM PLASMA AND POLYPEPTIDE CHAIN STRUCTURETACK BF; MORRIS SC; PRAHL JW et al.1979; BIOCHEMISTRY; USA; DA. 1979; VOL. 18; NO 8; PP. 1490-1497; BIBL. 40 REF.Article

GENETIC DEFECT IN SECRETION OF COMPLEMENT C5 IN MICEOOI YM; COLTEN HR.1979; NATURE; GBR; DA. 1979; VOL. 282; NO 5735; PP. 207-208; BIBL. 10 REF.Article

PRESERVATION OF C3, C5 AND C5A FUNCTIONAL ACTIVITIES BY A NEW RADIOLABELING METHOD; DEMONSTRATION OF C5 PRODUCTS IN COMPLEMENT-ACTIVATED SERUMKREUTZER DL; KUNKEL S; WARD PA et al.1979; J. IMMUNOL.; USA; DA. 1979; VOL. 123; NO 5; PP. 2278-2282; BIBL. 14 REF.Article

ABSENCE OF VARIATION IN HUMAN C5VAZ GUEDES MA; HOBART MJ; LACHMANN PJ et al.1978; J. IMMUNOGENET.; GBR; DA. 1978; VOL. 5; NO 4; PP. 279-282; BIBL. 23 REF.Article

CELL-MEDIATED SUPPRESSION OF THE FIFTH COMPONENT OF COMPLEMENT IN MICEGOLDMAN MB; FRENCH DL; GOLDMAN JN et al.1979; J. IMMUNOL.; USA; DA. 1979; VOL. 122; NO 1; PP. 246-252; BIBL. 29 REF.Article

C5 DEFICIENCY IN ONE ATOPIC FAMILY.BORZINI P; MAZZEI D.1977; BOLL. IST. SIEROTERAP. MILAN.; ITAL.; DA. 1977; VOL. 56; NO 2; PP. 198-199Article

C3 REQUIREMENTS FOR FORMATION OF ALTERNATIVE PATHWAY C5 CONVERTASE.DAHA MR; FEARON DT; AUSTEN KF et al.1976; J. IMMUNOL.; U.S.A.; DA. 1976; VOL. 117; NO 2; PP. 630-634; BIBL. 23 REF.Article

POLYMORPHISM OF HUMAN C5HOBART MJ; VAZ GUEDES MA; LACHMANN PJ et al.1981; ANN. HUM. GENET.; ISSN 0003-4800; GBR; DA. 1981; VOL. 45; NO 1; PP. 1-4; BIBL. 3 REF.Article

ANTIBODY-INDUCED SUPPRESSION OF THE FIFTH COMPONENT OF COMPLEMENT IN MICE.GOLDMAN JN; GOLDMAN MB.1978; J. IMMUNOL.; U.S.A.; DA. 1978; VOL. 120; NO 2; PP. 400-407; BIBL. 28 REF.Article

FUNCTIONAL STUDIES ON HUMAN PERITONEAL EOSINOPHILS.KLEBANOFF SJ; DURACK DT; ROSEN H et al.1977; INFECT AND IMMUN.; U.S.A.; DA. 1977; VOL. 17; NO 1; PP. 167-173; BIBL. 24 REF.Article

HEREDITARY C5 DEFICIENCY IN MAN. III. STUDIES OF HEMOSTASIS AND PLATELET RESPONSES TO ZYMOSAN.BRECKENRIDGE RT; ROSENFELD SI; GRAFF KS et al.1977; J. IMMUNOL.; U.S.A.; DA. 1977; VOL. 118; NO 1; PP. 12-16; BIBL. 28 REF.Article

Inactivation of interleukin-8 by the C5a-inactivating protease from serosal fluidAYESH, S. K; AZAR, Y; BABIOR, B. M et al.Blood. 1993, Vol 81, Num 6, pp 1424-1427, issn 0006-4971Article